日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages

针对SARS-CoV-2刺突蛋白RBD的抗体可介导原代人巨噬细胞的有效感染。

Suzanne Pickering ,Harry Wilson ,Enrico Bravo ,Marianne R Perera ,Jeffrey Seow ,Carl Graham ,Nathalia Almeida ,Lazaros Fotopoulos ,Thomas Williams ,Atlanta Moitra ,Helena Winstone ,Tinne A D Nissen ,Rui Pedro Galão ,Luke B Snell ,Katie J Doores ,Michael H Malim ,Stuart J D Neil

Unified metagenomic method for rapid detection of microorganisms in clinical samples

统一宏基因组学方法快速检测临床样本中的微生物

Adela Alcolea-Medina, Christopher Alder #, Luke B Snell #, Themoula Charalampous #, Alp Aydin, Gaia Nebbia, Tom Williams, Simon Goldenberg, Sam Douthwaite, Rahul Batra, Penelope R Cliff, Hannah Mischo, Stuart Neil, Mark Wilks, Jonathan D Edgeworth

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection

接种疫苗的个体在发生 Delta/BA.1 突破性感染后会产生广泛而有效的中和抗体

Jeffrey Seow #, Zayed A Shalim #, Carl Graham, Simon Kimuda, Aswin Pillai, Thomas Lechmere, Ashwini Kurshan, Atika M Khimji, Luke B Snell, Gaia Nebbia, Christine Mant, Anele Waters, Julie Fox, Michael H Malim, Katie J Doores

Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals

接受 REGN-COV2 治疗的 SARS-CoV-2 感染者的内源性抗体反应

Ashwini Kurshan, Luke B Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, Jonathan D Edgeworth, Gaia Nebbia, Katie J Doores

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals

在接种 COVID-19 疫苗的个体中,Delta 出现突破性感染后,包括 Omicron 在内的 SARS-CoV-2 变体被广泛中和

Thomas Lechmere #, Luke B Snell #, Carl Graham, Jeffrey Seow, Zayed A Shalim, Themoula Charalampous, Adela Alcolea-Medina, Rahul Batra, Gaia Nebbia, Jonathan D Edgeworth, Michael H Malim, Katie J Doores

Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London

伦敦市中心疫情流行期间入院特征的描述性比较和 SARS-CoV-2 Alpha 变体(B.1.1.7 谱系)与疾病严重程度关联的多变量分析

Luke B Snell #, Wenjuan Wang #, Adela Alcolea-Medina, Themoula Charalampous, Rahul Batra, Leonardo de Jongh, Finola Higgins, Gaia Nebbia; COG-UK HOCI Investigators; Yanzhong Wang, Jonathan Edgeworth, Vasa Curcin

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

SARS-CoV-2 及其相关变异株感染者恢复期血清中的中和抗体活性

Liane Dupont #, Luke B Snell #, Carl Graham #, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Thomas J A Maguire, Sadie R Hallett, Suzanne Pickering, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Jose M Jimenez-Guardeño, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E Dickenson, Rui

Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units

评估呼吸道宏基因组学在扩大的 COVID-19 重症监护病房中改善继发感染治疗和院内传播检测的潜力

Themoula Charalampous #, Adela Alcolea-Medina #, Luke B Snell #, Tom G S Williams, Rahul Batra, Christopher Alder, Andrea Telatin, Luigi Camporota, Christopher I S Meadows, Duncan Wyncoll, Nicholas A Barrett, Carolyn J Hemsley, Lisa Bryan, William Newsholme, Sara E Boyd, Anna Green, Ula Mahadeva, Am

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

SARS-CoV-2 第 1 波和 B.1.1.7 感染后的抗体寿命和交叉中和活性

Liane Dupont #, Luke B Snell #, Carl Graham #, Jeffrey Seow, Blair Merrick, Thomas Lechmere, Sadie R Hallett, Themoula Charalampous, Adela Alcolea-Medina, Isabella Huettner, Thomas J A Maguire, Sam Acors, Nathalia Almeida, Daniel Cox, Ruth E Dickenson, Rui Pedro Galao, Jose M Jimenez-Guardeño, Neoph